483 Response Zhejiang Tianyu Pharmaceutical Apr 2019

Laurimer Kuilan-Torres FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Tianyu Pharmaceutical - Taizhoushi, China facility and issued inspectional observation (via FDA 483) on 12 Apr 2019.

Product details

  • Category:
  • Inspection end: 12 Apr 2019
  • Location: Taizhoushi, China
  • FEI: 3010972581
Add To Cart